Total Funding
45
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 45 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
29030
Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care
Acquired by 
N-Power Medicine
- Michelle Kemling: Senior Vice President, People
- David Pomerantz: Chief Commercial Officer
About the Company
To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions that
matter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond.